Koers Compass Biotechnologies, Inc. Other OTC
Aandelen
US20452Q1031
Farmaceutische producten
Omzet 2018 | - | Omzet 2019 | - | Marktkapitalisatie | 158K 145K |
---|---|---|---|---|---|
Nettowinst (verlies) 2018 | - 0 | Nettowinst (verlies) 2019 | - 0 | EV/omzet 2018 | - |
Nettoschuld 2018 | 516K 474K | Nettoschuld 2019 | 480K 442K | EV/omzet 2019 | - |
K/w-verhouding 2018 |
-2,59
x | K/w-verhouding 2019 |
-3,95
x | Werknemers | - |
Dividendrendement 2018 * |
-
| Dividendrendement 2019 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Mathew Knowles
SAM | Sales & Marketing | - | 22-07-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18-04-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,38% | 6,28 mld. | |
-15,86% | 4,51 mld. | |
+6,36% | 3,35 mld. | |
-11,28% | 3,13 mld. | |
-3,23% | 2,47 mld. | |
+45,24% | 1,96 mld. | |
-7,89% | 1,68 mld. | |
-0,98% | 1,63 mld. | |
-11,32% | 1,56 mld. |